Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-3-28
pubmed:abstractText
Functional VIP/PACAP receptors were identified in the human glioblastoma cell line T98G, based on the relative potency of VIP, PACAP and PACAP-38 to stimulate adenylate cyclase activity. Analysis of the T98G cells mRNA by reverse transcription followed by a polymerase chain reaction (RT-PCR) demonstrated the expression of the mRNA coding for the VIP2 receptor subclass only. VIP, PACAP-27 and PACAP-38 were potent and efficIent inhibitors of cell proliferation, assessed by the colorimetric MTT assay. VIP, PACAP-27 and PACAP-38 also reduced the incorporation of 3H-thymidine in T98G cells, but did not significantly alter the percentage of cells present at each stage of the cell cycle. Thus, VIP and PACAP, probably acting through a VIP2 receptor subtype, decreased cell proliferation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/ADCYAP1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Adenylate Cyclase, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Growth Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptides, http://linkedlifedata.com/resource/pubmed/chemical/Pituitary Adenylate..., http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vasoactive Intestinal..., http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vasoactive Intestinal..., http://linkedlifedata.com/resource/pubmed/chemical/Vasoactive Intestinal Peptide
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0143-4179
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
491-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8923513-Adenylate Cyclase, pubmed-meshheading:8923513-Brain Neoplasms, pubmed-meshheading:8923513-Cell Cycle, pubmed-meshheading:8923513-Cell Division, pubmed-meshheading:8923513-DNA, Neoplasm, pubmed-meshheading:8923513-DNA Replication, pubmed-meshheading:8923513-Enzyme Activation, pubmed-meshheading:8923513-Glioblastoma, pubmed-meshheading:8923513-Growth Inhibitors, pubmed-meshheading:8923513-Humans, pubmed-meshheading:8923513-Neoplasm Proteins, pubmed-meshheading:8923513-Neuropeptides, pubmed-meshheading:8923513-Pituitary Adenylate Cyclase-Activating Polypeptide, pubmed-meshheading:8923513-Polymerase Chain Reaction, pubmed-meshheading:8923513-RNA, Messenger, pubmed-meshheading:8923513-Receptors, Vasoactive Intestinal Peptide, pubmed-meshheading:8923513-Receptors, Vasoactive Intestinal Peptide, Type II, pubmed-meshheading:8923513-Tumor Cells, Cultured, pubmed-meshheading:8923513-Vasoactive Intestinal Peptide
pubmed:year
1996
pubmed:articleTitle
VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor.
pubmed:affiliation
Laboratoire de Chimie Biologique et de la Nutrition, Université Libre de Bruxelles, Belgium.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't